TriCell

TriCell is a South Korean biotechnology company specializing in the development of next-generation cell therapies, with a core focus on Natural Killer (NK) cells and stem cell-derived treatments. The company utilizes a proprietary expansion and activation platform to produce high-purity NK cells designed to target and eliminate various cancers, including difficult-to-treat solid tumors. In addition to its oncology pipeline, TriCell is advancing regenerative medicine programs that leverage adipose-derived stem cells and exosomes for indications such as osteoarthritis. By focusing on scalable, "off-the-shelf" cell therapy solutions, TriCell aims to improve patient access to advanced immunotherapies and regenerative treatments.